, a major opportunistic pathogen in chickens, poses a serious threat to poultry production and public health via potential zoonotic transmission of ESBL-producing strains. Therefore, this study aimed to emphasize broilers as early carriers of ESBL and provide deeper insights into antimicrobial resistance of these bacteria. Prevalence and antimicrobial resistance (MIC) testing of ESBL in cloacal and environmental samples from one-day-old and five-day-old broilers was conducted on three different growth cycles from a conventional poultry farm in Lithuania. Confirmed prevalence of ESBL in cloacal samples ranged from 0% to 57.5%, and in environmental swabs from 0% to 25%. All 102 ESBL isolates were susceptible to meropenem, imipenem, fosfomycin, and colistin. However, 93.14% of the strains were resistant to ceftriaxone (89.06-100%, depending on bacteria isolation source), 97.06% to ciprofloxacin (95.31-100%), and 66.67% to tetracycline (26.09-100%). Additionally, 80.39% of ESBL strains exhibited multidrug resistance. In total, 23 different antimicrobial resistance profiles were confirmed, with CRO/AMS/AUG/CIP/SXT/TE and CRO/CIP being the most common, detected in 18 of the 102 strains. The detection of widespread antimicrobial-resistant ESBL in five-day-old broilers emphasizes the need to implement control strategies early in the broiler production cycle.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11858233 | PMC |
http://dx.doi.org/10.3390/microorganisms13020425 | DOI Listing |
Lab Med
March 2025
Department of Clinical Laboratory, People's Hospital of Dayi County, Chengdu Sichuan, China.
Introduction: Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP) is a highly pathogenic, drug-resistant, and transmissible "superbug" that causes infections in hospitals and communities. Because of the lack of effective antimicrobial treatment options, morbidity and mortality from CR-hvKP infections have increased dramatically, and outbreaks and the rapid spread of CR-hvKP in hospitals have become a major global public health challenge.
Methods: The mechanisms of molecular evolution in CR-hvKP include the acquisition of a hypervirulent plasmid encoding a virulence gene by carbapenemase-producing K pneumoniae, the horizontal transfer of plasmids carrying carbapenem resistance genes to hvKP, and the acquisition of fusion plasmids carrying both carbapenem resistance genes and hypervirulent genes by classic K pneumoniae.
Nanomaterials (Basel)
February 2025
Food Control Department, Faculty of Veterinary Medicine, Zagazig University, Zagazig 44511, Egypt.
The rise of multidrug-resistant (MDR) bacteria in food products poses a significant threat to public health, necessitating innovative and sustainable antimicrobial solutions. This study investigates the green synthesis of zinc oxide nanoparticles (ZnO-NPs) using extracts to evaluate their antibacterial and antibiofilm activities against MDR strains isolated from sold fish samples. The obtained results show that the contamination with reached 54.
View Article and Find Full Text PDFMycoses
March 2025
Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Oslo, Norway.
Background: Candida auris is an emerging fungal pathogen that is often multidrug-resistant. It can persist on skin and in hospital environments, leading to outbreaks and severe infections for patients at risk. Several countries and institutions are working on establishing guidelines and recommendations for prevention.
View Article and Find Full Text PDFCells
March 2025
Center for Viticulture & Small Fruit Research, Florida A&M University, Tallahassee, FL 32317, USA.
Muscadine grapes are renowned for their unique traits, natural disease resistance, and rich bioactive compounds. Despite extensive research on their phytochemical properties, microbial communities, particularly endophytic bacteria, remain largely unexplored. These bacteria play crucial roles in plant health, stress tolerance, and ecological interactions.
View Article and Find Full Text PDFMesenchymal stem/stromal cells (MSCs) offer promising therapeutic potential in cell-based therapies for various diseases. However, the safety of genetically modified MSCs remains poorly understood. This study aimed to evaluate the general toxicity and safety of Wharton's Jelly-Derived MSCs (WJ-MSCs) engineered to express the antimicrobial peptide SE-33 in an animal model.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!